Mucormycosis with orbital compartment syndrome in a patient with COVID-19
- PMID: 32972795
- PMCID: PMC7493738
- DOI: 10.1016/j.ajem.2020.09.032
Mucormycosis with orbital compartment syndrome in a patient with COVID-19
Abstract
During the current pandemic of COVID-19, a myriad of manifestations and complications has emerged and are being reported on. We are discovering patients with COVID-19 are at increased risk of acute cardiac injury, arrythmias, thromboembolic complications (pulmonary embolism and acute stroke), and secondary infection to name a few. I describe a novel case of COVID-19 in a previously healthy 33-year-old female who presented for altered mental status and proptosis. She was ultimately diagnosed with mucormycosis and orbital compartment syndrome, in addition to COVID-19. Early identification of these high morbidity conditions is key to allow for optimal treatment and improved outcomes.
Keywords: COVID-19; Mucormycosis; Orbital compartment syndrome.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Figures






References
-
- Cox G. 2020. Mucormycosis. Uptodate- July 2020.
-
- Jeong W., Keighley C., Wolfe R., et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26–34. - PubMed
-
- Chamilos G., Lewis R.E., Kontoyiannis D.P. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47:503–509. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical